4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000009
CFO AND TREASURER sold 21,000 shares at an average $478.60 ($10,050,597)
- CFO AND TREASURER acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +21,000 | $146.03 | $3,066,630 | 29,142 | D |
| 2025-12-08 | Sale : show line 2 in the form 10b5-1 | −400 | $475.08 | $190,034 | 28,742 | D |
| 2025-12-08 | Sale : show line 3 in the form 10b5-1 | −2,957 | $476.17 | $1,408,046 | 25,785 | D |
| 2025-12-08 | Sale : show line 4 in the form 10b5-1 | −6,529 | $477.18 | $3,115,502 | 19,256 | D |
| 2025-12-08 | Sale : show line 5 in the form 10b5-1 | −3,295 | $477.97 | $1,574,907 | 15,961 | D |
| 2025-12-08 | Sale : show line 6 in the form 10b5-1 | −3,139 | $479.16 | $1,504,074 | 12,822 | D |
| 2025-12-08 | Sale : show line 7 in the form 10b5-1 | −1,559 | $480.03 | $748,369 | 11,263 | D |
| 2025-12-08 | Sale : show line 8 in the form 10b5-1 | −477 | $481.22 | $229,544 | 10,786 | D |
| Open-market sales · 21,000 sh · avg $478.60 · $10,050,597 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option | −21,000 | $146.03 | 2027-03-15 | 21,000 | 3,517 | D |
Loading xslF345X05/primarydocument.xml…